Casper Steenholdt

20PUBLICATIONS
32CO-AUTHORS
Innate immunityIntensive careGene and molecular therapyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 15, 2026
Proactive Tight Monitoring of Patients with Inflammatory Bowel Disease in Biological Therapy: A Controlled Clinical Study (TIME IT).

|Feb 12, 2026
Acute severe ulcerative colitis without systemic toxicity: A retrospective multicenter cohort study suggesting refining the definition of acute severe ulcerative colitis.

Frederik Ørtoft, Mathilde Jepsen Nissen, Jens Kjeldsen

|Dec 26, 2025
MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).

Camilla Frimor, Casper Steenholdt, Ella Signe Kassandra Widigson

|Dec 24, 2025
Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review.

Frederikke Bindseil Culmsee-Holm, Emil Buhl, Mads Tjørnehøj Kraaer

|Dec 15, 2025
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization.

Zrinka Duvnjak, Robin Michelet, Casper Steenholdt

|Jun 18, 2025
Influence of Pharmacokinetic-Pharmacodynamic Failure Mechanisms on Outcomes in Biologic Therapy Sequencing in Inflammatory Bowel Disease: A Retrospective Cohort Study.

Casper Steenholdt, Ruben Due Lorentsen, Jon Henneberg

Pageof 4

Frequent Collaborators

4 joint publications

Mark Andrew Ainsworth

2 joint publications

Katrine Risager Christensen

2 joint publications

Robin Michelet

2 joint publications

Jens Kjeldsen